Interim results 2023
Key highlights include 7% continuing revenue growth; continuing adjusted profit before tax of £8.9m, up 14%; and total dividend up 13% to 2.70p.
Mark Milner, Chief Executive Officer, commented:
"We continue to deliver our strategy to drive solid organic revenue growth and profits as well as strong cash conversion. We maintain focus on actively managing our portfolio and will only consider acquisition opportunities which provide attractive return on investment.
“We have made good progress with our endeavours to develop single platforms for our Intelligence and Training & Education divisions, simplifying our technology and enhancing our products and services.
“Trading in the current financial year continues to be in line with expectations. Whilst we are mindful of current economic uncertainties, we have a strong contracted order book which underpins our confidence for the second half.”
![Sale of UK Healthcare Business](https://wilmingtonplc.com/sites/default/files/styles/news_270_152_/public/2024-06/CD-18274_0.jpg.webp?itok=mAZ8HN2G)
News
Sale of UK Healthcare Business
Wilmington has completed the sale of its UK Healthcare business to Inspirit Capital.
Read More![Sale of APM International](https://wilmingtonplc.com/sites/default/files/styles/news_270_152_/public/2024-06/CD-18274_0.jpg.webp?itok=mAZ8HN2G)
News
Sale of APM International
Wilmington plc, has sold its French healthcare business, APM International to Philia Medical Editions SAS, a subsidiary of Europa Group.
Read More![Congratulations FRA!](https://wilmingtonplc.com/sites/default/files/styles/news_270_152_/public/2024-05/Untitled%20design%20%285%29.jpg.webp?itok=Tsm8n93G)
News
Congratulations FRA!
Congratulations to the FRA team in the US who last week successfully certified to the ISO Event Sustainability Standard (ISO20121), with no audit findings.
Read More